2,6,6-三甲基-双环[3,1,1]庚基-3-(4-芳基-2-噻唑)腙类化合物的合成及其抑菌和抗肿瘤活性研究
收稿日期: 2014-04-26
修回日期: 2014-05-22
网络出版日期: 2014-06-11
基金资助
国家自然科学基金(No. 31170538)、江苏省教育厅优势学科经费(No. 201104015)资助项目.
Synthesis and Antibacterial, Antitumor Activity of 2,6,6-Thrimethyl- bicyclo[3,1,1]heptan-3-(4-aryl-2-thiazoyl)hydrazones
Received date: 2014-04-26
Revised date: 2014-05-22
Online published: 2014-06-11
Supported by
Project supported by the National Natural Science Foundation of China (No. 31170538) and the Forestry Public Sector Research Found of State Forestry Administration of China (No. 201104015)
以α-蒎烯为起始原料,经加成、氧化、缩合制得中间体,继而与α-溴代芳基乙酮在常温下反应合成12个新型2,6,6-三甲基-双环[3,1,1]庚基-3-(4-芳基-2-噻唑)腙类化合物,产率达52.4%~88.9%. 其结构经1H NMR,13C NMR,IR,LC/MS和元素分析进行了确证. 初步生物活性测试结果表明:部分目标化合物具有较好的抑菌活性和一定的抗肿瘤活性.
关键词: 庚基-3-(4-芳基-2-噻唑)腙; 合成; 抑菌活性; 抗肿瘤活性
鲍名凯 , 杨益琴 , 谷文 , 徐徐 , 曹明珍 , 王石发 . 2,6,6-三甲基-双环[3,1,1]庚基-3-(4-芳基-2-噻唑)腙类化合物的合成及其抑菌和抗肿瘤活性研究[J]. 有机化学, 2014 , 34(10) : 2146 -2151 . DOI: 10.6023/cjoc201404049
Twelve new 2,6,6-thrimethyl-bicyclo[3,1,1]heptan-3-(4-aryl-2-thiazoyl)hydrazones were synthesized by using α-pinene as starting material in four steps reaction including addition, oxidation, condensation, and reaction with α-bromo- acetophenone under room temperature. The yields of products were in the range from 52.4% to 88.9%. All synthesized new compounds were confirmed by 1H NMR, 13C NMR, IR, LC/MS spectra and elemental analysis. The preliminary bioassay showed that some of the target compounds exhibited significant antibacterial activity and certain antitumor activity.
[1] Khare, M.; Keady, D. Expert Opin. Pharm. 2003, 4, 165
[2] Vicini, P.; Geroniki, A.; Anastasia, K. Bioorg. Med. Chem. 2006, 14, 3859.
[3] Bell, F. W.; Cantrell, A. S.; Hoegberg, M. J. Med. Chem. 1995, 38, 4929
[4] Sharma, P. K.; Sawheny, S. N. Bioorg. Med. Chem. Lett. 1997, 7, 2427.
[5] Vicini, P.; Geronikakib, A.; Incertia, M. Bioorg. Med. Chem. 2003, 11, 4785.
[6] Lu, Y. Y.; Li, C. M.; Wang, Z. J. Med. Chem. 2009, 52, 1701.
[7] Turan, G. Z.; Kaplancikli, A.; Yildiz, M. T.; Chevallet, P.; Kaya, D. Eur. J. Med. Chem. 2005, 40, 607.
[8] Cukurovali, A.; Yilmaz, I.; Gur, S.; Kazaz, C. Eur. J. Med. Chem. 2006, 41, 201.
[9] Shi, H. B.; Zhang, S. J.; Ge, Q. F.; Guo, D. W.; Cai, C. M.; Hu, W. X. Bioorg. Med. Chem. Lett. 2010, 20, 6555.
[10] Khan, S. A. Eur. J. Med. Chem. 2008, 43, 2040.
[11] Merlani, M. I.; Amiranashvili, L. S.; Mulkidzhanyan, K. G.; Shelar, A. R.; Manvi, F. V. Chem. Nat. Compd. 2008, 44, 618.
[12] Iványi, Z.; Wölfling, J.; Görbe, T.; Szécsi, M.; Wittmann, T.; Schneider, G. Steroids 2010, 75, 450.
[13] Bizzarri, B.; Chimenti, F.; Secci, D.; Bolsaco, A. Granese, A. Bioorg. Med. Chem. 2007, 17, 4635.
[14] Gulhan, T. Z.; Ahmet, O.; Zafer, A. K.; Kadriye, B.; Pierre, C.; Gulsen, A. Eur. J. Med. Chem. 2008, 43, 981.
[15] Caputto, M. E.; Ciccarelli, A.; Frank, F.; Moglioni, A. G. Eur. J. Med. Chem. 2012, 35, 155.
[16] Yuan, M. Y.; Liu, W. H.; Zhang, Y, Q.; Yan, H. F.; Zhang, D. N.; Liu, H. M.; Wang, J. P. Chin. J. Org. Chem. 2013, 33, 1108 (in Chinese).
(袁明月, 刘伟华, 张英群, 闫红飞, 张冬暖, 刘卉闵, 王建平, 有机化学, 2013, 33, 1108.)
[17] Wang, S. F.; Li, Y. P.; Zhang M. G. J. Org. Chem. 2007, 27, 1612 (in Chinese).
(王石发, 李艳苹, 张明光, 有机化学, 2007, 27, 1612.)
/
〈 |
|
〉 |